Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis.
Purpose: To investigate the impact of amyloid PET with [18F]flutemetamol on diagnosis and treatment management in a cohort of patients attending a tertiary memory clinic in whom, despite extensive cognitive assessment including neuropsychological testing, structural imaging, CSF biomarker analysis a...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 46; no. 6; pp. 1276 - 1287 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |